How many insider trades does FilingIQ track for NVCT?

FilingIQ tracks 184 Form 4 insider transactions for NVCT (Nuvectis Pharma, Inc.), covering filings from Feb 4, 2022 onwards. 4 of those were filed in the last 90 days.

Are NVCT insiders net buyers or net sellers?

Across the full Form 4 history for NVCT, 151 transactions (82%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NVCT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NVCT in?

Nuvectis Pharma, Inc. (NVCT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $210.87M.

NVCT insider trading

NasdaqCM Healthcare

Nuvectis Pharma, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

184

Last 90 days

Buys / sells

82% / 1%

Market cap

$210.87M

About Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

Company website: www.nuvectis.com

NVCT insider activity at a glance

FilingIQ has scored 184 insider transactions for NVCT since Feb 4, 2022. The most recent filing in our index is dated Jun 11, 2026.

Across the full history, 151 open-market purchases and 1 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NVCT insider trades is 44.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NVCT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,223

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 152

Guardant Health, Inc.

KalVista Pharmaceuticals, Inc.

KNSA 129

Kiniksa Pharmaceuticals International, plc

Frequently asked

How many insider trades does FilingIQ track for NVCT?: FilingIQ tracks 184 Form 4 insider transactions for NVCT (Nuvectis Pharma, Inc.), covering filings from Feb 4, 2022 onwards. 4 of those were filed in the last 90 days.
Are NVCT insiders net buyers or net sellers?: Across the full Form 4 history for NVCT, 151 transactions (82%) were open-market purchases and 1 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NVCT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NVCT in?: Nuvectis Pharma, Inc. (NVCT) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $210.87M.

Methodology & sources

Every NVCT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.